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Abstract
Cryptosporidium parvum is a protozoan parasite that infects the gastrointestinal epithelium and causes diarrheal disease
worldwide. Innate epithelial immune responses are key mediators of the host’s defense to C. parvum. MicroRNAs (miRNAs)
regulate gene expression at the posttranscriptional level and are involved in regulation of both innate and adaptive
immune responses. Using an in vitro model of human cryptosporidiosis, we analyzed C. parvum-induced miRNA expression
in biliary epithelial cells (i.e., cholangiocytes). Our results demonstrated differential alterations in the mature miRNA
expression profile in cholangiocytes following C. parvum infection or lipopolysaccharide stimulation. Database analysis of C.
parvum-upregulated miRNAs revealed potential NF-kB binding sites in the promoter elements of a subset of miRNA genes.
We demonstrated that mir-125b-1, mir-21, mir-30b, and mir-23b-27b-24-1 cluster genes were transactivated through
promoter binding of the NF-kB p65 subunit following C. parvum infection. In contrast, C. parvum transactivated mir-30c and
mir-16 genes in cholangiocytes in a p65-independent manner. Importantly, functional inhibition of selected p65-dependent
miRNAs in cholangiocytes increased C. parvum burden. Thus, we have identified a panel of miRNAs regulated through
promoter binding of the NF-kB p65 subunit in human cholangiocytes in response to C. parvum infection, a process that may
be relevant to the regulation of epithelial anti-microbial defense in general.
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Introduction
The protozoan parasite, Cryptosporidium parvum, is a causative
agent of human gastrointestinal disease worldwide [1]. C. parvum
infects the gastrointestinal epithelium to produce a self-limiting
diarrhea in immunocompetent individuals but is potentially life-
threatening in immunocompromised persons, especially those with
the acquired immunodeficiency syndrome (AIDS) [1,2]. Trans-
mission occurs via the fecal-oral route. Humans are infected by
ingesting C. parvum oocysts; oocysts then excyst in the gastrointes-
tinal tract releasing infective sporozoites. C. parvum sporozoites can
also travel up the biliary tract to infect the epithelial cells lining the
biliary tract (i.e. cholangiocytes) [1,3]. Mediated by specific ligands
on the sporozoite surface and receptors on the host cells, the
sporozoite attaches to the apical membrane of epithelial cells and
forms a parasitophorous vacuole in which the organism remains
intracellular but extracytoplasmic [3]. The sporozoite then
matures and undergoes further development of its life cycle. With
this unique extracytoplasmic niche within epithelial cells prevent-
ing a direct infection of other cell types, C. parvum is classified as a
‘‘minimally invasive’’ mucosal pathogen [1].
Because of the ‘‘minimally invasive’’ nature of C. parvum
infection, innate immune responses by epithelial cells are critical
to the host’s defense against infection. Toll-like receptor (TLR) -
and nuclear factor-kappaB (NF-kB) -mediated signaling pathways
are important components in epithelial innate immunity to C.
parvum infection [4,5]. TLRs are transmembrane proteins with
highly conserved structural domains [6]. Upon engagement of the
TLRs by specific ligands, various adaptor molecules including
myeloid differentiation factor 88 (MyD88) are selectively recruited
to the receptors forming a complex referred to as the ‘‘signalo-
some’’ [6,7]. The signalosome then triggers a series of downstream
events including activation of the NF-kB [6–8]. NF-kB subunits
bind to the kB sites within the promoters/enhancers of target
genes resulting in the transcriptional regulation of multiple genes
important to epithelial anti-C. parvum defense [4,5].
MicroRNAs (miRNAs), a newly identified class of endogenous
smallregulatory RNAs of ,24nucleotides,areemergingaskeymedi-
ators of many biological processes and impact gene expression at the
posttranscriptional level [9,10]. Similar to other RNA molecules,
most of miRNAs are initially transcribed as primary transcripts
(termed pri-miRNAs) by Poly II and processed by the RNase III
Drosha (in the nucleus) and a second RNase III Dicer (in the
cytoplasm) to generate mature miRNA molecules [11–13]. However,
molecular mechanisms underlying miRNA gene transcriptional
regulation are largely unclear [14]. Recent studies on expression of
miRNA genes have revealed potential transcriptional regulation by
transcription factors, such as NF-kBa n dC / E B P a [15,16].
PLoS Pathogens | www.plospathogens.org 1 December 2009 | Volume 5 | Issue 12 | e1000681While much of our understanding of the cellular processes
modulated by miRNAs has come from studies on development
and tumorigenesis, the role of miRNAs in immune responses is
now being gradually uncovered [17–19]. The importance of
miRNAs in cell-mediated immunity is highlighted by Dicer
conditional knockout mice. Specific deletion of dcr-1 in the T cell
lineage resulted in impaired T cell development and aberrant T
helper cell differentiation and cytokine production [20]. In
addition, miRNA expression is impacted by cytokines in some
model systems. Both interferon (IFN) -a and IFN-b modulate
expression of several miRNAs required for their anti-viral
responses following infection with hepatitis C virus [21]. The
TLR4 ligand, lipopolysaccharide (LPS), impacts expression of
miR-132, miR-146, and miR-155 in human THP-1 monocytes
[15,22]. Further characterization of miR-146 revealed that this
miRNA may function as a negative regulator of tumor necrosis
factor receptor-associated factor 6 and interleukin-1 receptor
associated kinase 1 [15]. Recent studies also implicate specific
miRNAs in controlling various epithelial cell processes such as
regulation of cellular differentiation, determination of epithelial
cell fate (cell death and proliferation), initiation and regulation of
anti-microbial immunity, fine-tuning of inflammatory responses,
and activation of specific intracellular signaling pathways [17–
19,23]. Using a non-malignant human cholangiocyte cell line
(H69) that expresses multiple TLRs including TLR4 [5], we
previously demonstrated that infection of human cholangiocytes
by C. parvum in vitro mimics parasitial apical invasion and TLR4/
NF-kB-dependent epithelial responses in vivo [3]. Moreover, let-7
regulates TLR4 expression via translational suppression in human
cholangiocytes and is involved in epithelial defenses against C.
parvum [24]. Members of the miR-98/let-7 family also regulate
expression of cytokine-inducible SH2-containing protein (CIS) in
cholangiocytes following C. parvum infection [25]. Together, these
findings demonstrate that miRNAs levels in epithelial cells are
altered by C. parvum infection and may regulate epithelial anti-C.
parvum immune responses.
In this study, we performed an array analysis of miRNA
expression in H69 cells following C. parvum infection and LPS
stimulation. The analysis revealed significant alterations in
miRNA expression in cholangiocytes following C. parvum infection
or treatment with LPS. Of those miRNAs upregulated by C.
parvum infection, we identified potential NF-kB binding sites in the
promoter elements of several miRNA genes. Inhibiting activation
of NF-kB p65 blocked C. parvum-induced upregulation of a panel
of miRNA genes. Promoter binding and transactivation of the NF-
kB p65 subunit of each selected miRNA gene was confirmed by
chromatin immunoprecipitation assay and promoter luciferase
reporter analysis. Furthermore, functional inhibition of the NF-kB
p65-binding miRNAs increased C. parvum burden in cholangio-
cytes in vitro. These data demonstrate that a panel of miRNAs is
regulated through promoter binding of the NF-kB p65 subunit in
human cholangiocytes and these miRNAs are involved in
epithelial defense in response to C. parvum infection, suggesting a
role of miRNAs in regulation of epithelial anti-microbial defense.
Results
C. parvum infection induces alterations in miRNA
expression in cholangiocytes in vitro
To globally assess miRNA expression in epithelial cells following
C. parvum infection, we performed a microarray analysis of mature
miRNA expression in H69 cells [26]. The miRCURY
TM LNA
humanmicroRNAsassays(version8.1;Exiqon;Vedbaek,Denmark)
covers a total of up to 600 known human mature miRNAs and were
used as previously described [27]. The quality of the RNA was
verifiedusing anAgilent 2100Bioanalyzer (Figure S1). A total of 383
mature miRNAs were detected in the uninfected H69 cells. Of the
miRNAs expressed, miR-23b, miR-30b, miR-30c, and miR-125b
expression were significantly increased in H69 cells after exposure to
live C. parvum infection for 12 h (p,=0.05; Figure 1A and Table
S1). Five additional miRNAs (miR-15b, miR-16, miR-27b, miR-24,
and miR-21) showed a tendency to increase (0.05,p,=0.20)
(Figure 1A). A total of 19 miRNAs were significantly downregulated
(p,=0.05) and 30 additional miRNAs showed a tendency to
decrease (0.05,p,=0.20) following C. parvum infection (Figure 1A
and Table S1). Sham-infected control cells (H69 cells exposed to
heat-inactivated C. parvum oocysts after incubation at 65uCf o r
30 min) displayed a similar miRNA expression profile as non-
infected control samples (Table S1). Microarray analysis of mature
miRNAs was also performed on H69 cells treated with LPS (1 mg/
ml for 8 h). Interestingly, most of the miRNAs upregulated by C.
parvum also displayed an increased expression in cells treated by LPS
(Figure 1B and Table S1). Nevertheless, increased expression of
additional 13 miRNAs was identified in LPS-treated cells but not in
cells exposed to C. parvum. A total of 31 miRNAs showed a decreased
expression in LPS-treated cells and 10 of them were also
downregulated by C. parvum (Figure 1B and Table S1). No LPS
contamination in the C. parvum preparation was detected using the
Limulus Amebocyte Lysate (LAL) test kit (Bio-Whittaker) (data not
shown). All microarray data were described in accordance with
MIAME guidelines and deposited at ArrayExpress (accession
number: E-MEXP-2050 and E-MEXP-2052).
Real-time PCR analysis using primers and probes for mature
miRNAs (Ambion) was performed to assess the kinetics of selected
miRNAs in H69 cells following C. parvum infection. Increased
expression of miR-125b, miR-21, miR-23b, miR-30b and miR-16
was detected in H69 cells following C. parvum infection for 12 h to
24 h, but not in the early time points (2 h to 8 h) (Figure 2A).
Increased expression of miR-125b, miR-16, miR-23b, miR-21 and
miR-30b, as well as decreased expression of miR-98, was further
Author Summary
MicroRNAs (miRNAs) are newly identified small non-coding
RNAs that regulate gene expression at the posttranscrip-
tionallevel.While muchof ourunderstanding of the cellular
processes modulated by miRNAs has come from studies on
development and tumorigenesis, the role of miRNAs in
immune responses is now being gradually uncovered.
Nevertheless, whether miRNA-mediatedposttranscriptional
gene regulation is involved in the fine-tuning of epithelial
cell immune responses against pathogen infection remains
undefined. Cryptosporidium parvum is a protozoan parasite
that infects gastrointestinal epithelium. TLR/NF-kB-mediat-
ed innate immune responses by epithelial cells are critical
to the host’s defense to infection. Using an in vitro model of
human cryptosporidiosis, we show here differential alter-
ations in the miRNA expression profile in biliary epithelial
cells following C. parvum infection. Promoter binding of NF-
kB p65 subunit accounts for the upregulation of a panel of
miRNA genes in cells infected by C. parvum. Importantly,
functional inhibition of several NF-kB p65-dependent
miRNAs in epithelial cells increases C. parvum infection
burden. Our findings suggest that host epithelial cells
activate NF-kB signaling to regulate miRNA expression in
response to C. parvum infection. Moreover, NF-kB-mediat-
ed miRNA expression is involved in epithelial anti-microbial
defense. Our study provides new insights into epithelial cell
immunoregulation.
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PLoS Pathogens | www.plospathogens.org 2 December 2009 | Volume 5 | Issue 12 | e1000681Figure 1. Expression profiling of mature miRNAs in cholangiocytes following C. parvum infection and LPS stimulation. (A) miRNA
expression profile in H69 cells following C. parvum infection. The left panel shows a heat-map of selected miRNAs that showed changes in expression
in H69 cells following C. parvum infection. The horizontal axis indicates samples of non-infected cells (n=3; Control-1, -2, and -3) and cells after
exposure to live C. parvum for 12 h (n=3, C. parvum-1, -2, and -3). The right panel shows expression of miRNAs in H69 cells following C. parvum
infection. Cellular levels of miRNAs were presented as the log2 (Hy5/Hy3) ratios which passed the filtering criteria variation across the samples. p
values are from the t’ test. hsa=Homo sapiens. (B) Comparison of miRNA expression patterns in H69 cells following C. parvum infection for 12 h and
LPS stimulation for 8 h. Graphics indicate those miRNAs showing an increased or decreased expression (including those significant change when
p,=0.05 and those with a tendency to change when 0.05,p,=0.20) in cells after treatment with LPS (n=3) or exposure to C. parvum (n=3). A
complete description of miRNA expression profiles in cells was listed in Table S1.
doi:10.1371/journal.ppat.1000681.g001
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blot (Figure 2B). An increased expression of the precursors for miR-
125b, miR-16, miR-21 and miR-23b was also detected in cells
following C. parvum infection by Northern blot (Figure 2B). No
positive signal for the above human miRNAs was detected in C.
parvum RNA using the probes or primers for miRNA real-time PCR
(data not shown) and Northern blot (Figure 2C), demonstrating the
specificity of these probes for human miRNAs. Downregulation of
selected miRNAs induced by C. parvum, including miR-98, miR-320
and miR-424, was further confirmed by bead-based multiplexed
miRNA expression assay using the FlexmiR
TM Select kit
(Figure 2D). For those miRNAs that did not show significant
alterations in cells following C. parvum infection as revealed by the
microarray analysis, we selected miR-326 for bead-based multi-
plexed analysis and no change was detected in C. parvum infected
cells (Figure 2D), further confirming the accuracy of the array data.
Database analysis of upregulated miRNAs in
cholangiocytes following C. parvum infection reveals
potential NF-kB binding sites in their promoter elements
Differential alterations in the mature miRNA expression profile
of C. parvum-infected H69 cells suggest that miRNA gene
expression is finely controlled in epithelial cells in response to C.
parvum infection. One potential mechanism for selectively altering
miRNA levels is through activation of distinct intracellular
signaling pathways and nuclear transcription factors [15,16].
This mechanism is consistent with our previous data demonstrat-
ing that C. parvum infection activates the NF-kB pathway in
cholangiocytes through microbial recognition of TLR4 and TLR2
[28]. We hypothesized that activation of the NF-kB pathway is
involved in the transcription of select miRNAs upregulated by C.
parvum. Based on TFSEARCH (http://www.cbrc.jp/research/db/
TFSEARCH.html) and MOTIF (http://motif.genome.jp/) data-
base searches [29,30], many of these miRNA genes have putative
NF-kB binding sites in their potential promoter elements [31–34]
(Table 1). Several miRNAs upregulated in H69 following C. parvum
infection are cluster miRNAs; e.g., miR-23b, miR-27b and miR-
24 are from the mir-23b-27b-24-1 gene cluster and miR-15b and
miR-16 from the mir-15b-16-2 cluster [31,32]. The promoters of
the mir-125b-1 and mir-30b genes have not been characterized and
it is unknown whether they have potential NF-kB binding sites.
Transactivation of most NF-kB-dependent genes requires NF-kB
p65 binding to the promoter [8] and nuclear translocation of p65
was demonstrated following C. parvum infection of cholangiocytes
[28]. Coupled with the results showing some similar changes in
miRNA expression in H69 cells treated with LPS (which activates
TLR4/NF-kB signaling in H69 cells), we then focused on
determining whether p65 binds to the promoter and transactivates
the miRNA genes upregulated by C. parvum infection.
Differential expression of primary transcripts of C.
parvum-upregulated mature miRNAs in H69 cells
We then analyzed the kinetics of alterations of the primary
transcripts (pri-miRNAs) for select mature miRNAs upregulated
by C. parvum as listed in Table 1. H69 cells were exposed to C.
parvum for various periods of time and pri-miRNAs of interests
were quantified by real-time PCR (primers listed in Table S2).
Expression of pri-miR-125b-1, pri-miR-21, pri-miR-23b-27b-24-
1, pri-miR-30b, pri-miR-30c-1, pri-miR-15a-16-1, and pri-miR-
15b-16-2 showed a time-dependent increase in cells following C.
parvum infection, with a peak at 8 h or 12 h after exposure to the
parasite (Figure 3). In contrast, no significant increase of pri-miR-
125b-2 and pri-miR-30c-2 was detected in cells after exposure to
Figure 2. Altered expression of selected miRNAs confirmed by
real-time PCR, Northern blot and Luminex bead analyses. (A)
Alterations of selected miRNA expression in cells after exposure to C.
parvum for various periods of time as assessed by real-time PCR. The
amount of mature miRNAs was obtained by normalizing to the level of
snRNA RNU6B in the samples. Data are expressed as the amount of
mature miRNAs in the infected samples relative to the control
uninfected samples and representative of three independent experi-
ments. (B) Alterations of selected miRNA expression in cells after
exposure to C. parvum for 12 h as determined by Northern blot. snRNA
RNU6B was used as a control to ensure equal loading. Representative
Northern blots (C. parvum infected cells vs non-infected control) from
three independent experiments are shown. (C) Total RNA isolated from
C. parvum oocysts was also blotted to demonstrate the specificity of the
probes. (D) Alterations of selected miRNA expression in cells after
exposure to C. parvum for 12 h as assessed by bead-based miRNA
Luminex analysis. The amount of mature miRNAs was obtained by
normalizing the samples to the positive control beads provided by the
company (Luminex). Data are representative of three independent
experiments. *, p,0.05 vs. the non-infected control.
doi:10.1371/journal.ppat.1000681.g002
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the primary transcripts of C. parvum-upregulated miRNAs.
Promoter binding of NF-kB p65 subunit is required for
the transcription of select miRNA genes induced by C.
parvum in H69 cells
To test whether NF-kB p65 subunit is involved in C. parvum-
induced transactivation of pri-miR-125b-1, we exposed H69 cells
to C. parvum infection in the presence of SC-514, an IKK2
inhibitor that prevents p65-associated transcriptional activation of
the NF-kB pathway [35]. SC-514 blocked the C. parvum-induced
increase of pri-miR-125b-1 (Figure 4A). To further test the
potential transactivation of mir-125b-1 gene by p65 subunit, rapid
amplification of 59 complementary DNA ends (59-RACE) PCR
was used to identify the 59 end of pri-miR-125b-1. Primers were
designed to amplify pri-miR-125b-1 based on the sequence
obtained from the Sanger miRNA Registry (Table S2). Database
analysis revealed two potential p65 binding sites in the upstream
Table 1. Analysis of C. parvum-upregulated miRNAs in cholangiocytes reveals potential transactivation of their genes by NF-kB.
Mature miRNAs miRNA genes (or cluster) Chromosome (strand) Host gene Predicted NF-kB binding sites (from miRNA TSS) Reference
miR-125b mir-125b-1 11 (2) None Promoter element unknown [31]
mir-125b-2 21 (+) C21orf34 GAGAATTTCC (2893 to 2884)
miR-21 mir-21 17 (+) None GGGAATTTTC (+1167 to +1176) [33,34]
GGGAATTCTC (+1395 to +1404)
miR-23b mir-23b-27b-24-1 9( +) C9orf3 GGGACTCTCC (21263 to 21254) [31]
miR-27b
miR-24
miR-30b mir-30b 8( 2) None Promoter element unknown
miR-30c mir-30c-1 1( +) NFYC TGGAATTACC (2689 to 2680) [31,32]
mir-30c-2 6( 2) C6orf155 TGGGCTTTCC (2208 to 2199)
miR-16 mir-15a-16-1 13 (2) DLEU2 None [32]
miR-15a
miR-16 mir-15b-16-2 3( +) SMC4 GGGATTTACC (2504 to 2495) [32]
miR-15b
MicroRNA genes related to C. parvum-upregulated mature miRNAs, their chromosomal location and co-expressed host genes were identified by the miRBase (http://
microrna.sanger.ac.uk/) database search and confirmed by previous studies as referred. Potential promoter element for each miRNA was based on the referred studies
and potential NF-kB binding sites were identified by the TFSEARCH (http://www.cbrc.jp/research/db/TFSEARCH.html) and MOTIF (http://motif.genome.jp/) search.
doi:10.1371/journal.ppat.1000681.t001
Figure 3. Differential expression of primary transcripts of C. parvum-upregulated mature miRNAs in H69 cells. H69 cells were exposed
to C. parvum for 2 h to 24 h and primary transcripts (pri-miRNAs) of select miRNAs were quantified by real-time PCR. The amount of pri-miRNAs was
obtained by normalizing to the level of GAPDH in the samples. Data are expressed as the amount of pri-miRNAs in the infected samples relative to
the control uninfected samples and representative of three independent experiments. *, p,0.05 vs. the non-infected control.
doi:10.1371/journal.ppat.1000681.g003
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PLoS Pathogens | www.plospathogens.org 5 December 2009 | Volume 5 | Issue 12 | e1000681Figure 4. Promoter binding of p65 transactivates miR-125b-1 gene to increase miR-125b expression following C. parvum infection. (A)
p65-dependent upregulation of pri-miR-125b-1 in cholangiocytes following C. parvum infection. Data are presented as the relative expression level of
pri-miR-125b-1 in H69 cells following C. parvum infection in the presence or absence of SC-514 as assessed by real-time PCR. (B) C. parvum increases
promoter element binding of p65 to mir-125b-1 gene. The schematic diagram shows two potential binding sites in the putative promoter element of
mir-125b-1 gene. ChIP analysis revealed increased binding of p65 to the binding site at 21059, but not at 22455, of mir-125b-1 promoter element in
cells following infection. Representative ChIP gels are shown in the upper panel and densitometry analysis of the gels in the lower panel. (C) H69 cells
were transfected with various luciferase reporter constructs spanning the potential p65 binding sites of the mir-125b-1 promoter. The transfected
cells were exposed to C. parvum in the presence or absence of SC-514. Luciferase activity was measured and presented as the ratio of the activity of
the test construct with the control luciferase reporter construct. Six reporter constructs containing the mutants of the two potential NF-kB binding
sites were also utilized for the analysis as indicated. (D) H69 cells were co-transfected with the pCMV-p65 to overexpress p65 and the luciferase
reporter construct containing the mir-125b-1 promoter for 24 h followed by measurement of luciferase activity. *, p,0.05 vs. the non-infected control
(in A and C) or empty pCMV vector control (in D);
#,p ,0.05 vs. C. parvum infected cells (in A and C).
doi:10.1371/journal.ppat.1000681.g004
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the binding site at 21059, but not the putative binding site at
22455, in the promoter element of mir-125b-1 gene (Figure 4B)
was demonstrated by chromatin immunoprecipitation (ChIP)
analysis using specific primers for each putative binding site
(Table S2). C. parvum-induced transactivation of the mir-125b-1
gene by p65 was further confirmed by using luciferase reporter
gene constructs that spanned the mir-125b-1 promoter (Figure 4C).
C. parvum infection increased luciferase activity in cells transfected
with the luciferase constructs that encompassed the binding site for
p65 at 21059 in the promoter region of mir-125b-1 gene. A
mutant of the p65 binding site at 21059 blocked C. parvum-
induced luciferase activity. In addition, SC-514 significantly
inhibited the increase of luciferase activity induced by C. parvum
infection (Figure 4C). Moreover, p65-associated transactivation of
the mir-125b-1 promoter was also confirmed by the upregulation of
luciferase activity after p65 overexpression in the cells (Figure 4D).
As an additional control, we analyzed IL-8 transactivation, a p65-
dependent process induced by C. parvum in epithelial cells [36].
NF-kB p65-dependent increase of IL-8 mRNA expression and
binding of p65 to the promoter of IL-8 gene in cells exposed to C.
parvum were confirmed (Figure S2). Together, these data
demonstrate that p65 binding to the promoter element of the
mir-125b-1 gene mediates mir-125b upregulation in H69 cells in
response to C. parvum infection. The dynamics of p65 nuclear
translocation were confirmed by Western blot analysis of p65 in
the nuclear extracts from H69 cells following C. parvum infection
(Protocol S1 and Figure S3), correlated to the kinetics of C. parvum-
induced expression of pri-miRNAs in cells (Figure 3). Consistent
with previous results, maximal p65 translocation was observed at
8 h after exposure to C. parvum [5].
Using the same approaches, we analyzed p65 promoter element
binding in C. parvum-induced transcription of pri-miR-21, pri-miR-
23b-27b-24-1, pri-miR-30b, pri-miR-30c-1, pri-miR-30c-2, pri-
miR-15a-16-1, and pri-miR-15b-16-2. Our data are summarized
in Table 2 and presented in detail in Figures S4, S5, S6 and S7.
Specifically, p65 binding to the putative p65 binding site around
+1395 of the mir-21 gene appears to be associated with C. parvum-
induced transcription of pri-miR-21 (Figure S4). C. parvum
increases transcription of pri-miR-23b-27b-24-1 cluster, as well
as the host gene transcript, C9orf3, via promoter binding of p65 to
a binding site at 21254 of the immediate upstream of the gene
(Figure S5). Increased transcription of pri-miR-30b induced by C.
parvum is p65-dependent (Figure S6). Nevertheless, it appears that
C. parvum infection increases transcription of pri-miR-30c-1, pri-
miR-15a-16-1 and pri-miR-15b-16-2 in cholangiocytes through a
p65-independent mechanism (Figure S7).
Functional inhibition of selected p65-dependent miRNAs
in cholangiocytes increases C. parvum infection burden
To test whether miRNAs are involved in cholangiocyte defense
responses against C. parvum infection, we assessed parasite burden
over time in cultured cholangiocytes transfected with various anti-
miRs thereby inhibiting function of specific C. parvum-upregulated
miRNAs. Anti-miRs (anti-miR
TM miRNA inhibitors) are com-
mercially available, chemically modified single stranded nucleic
Table 2. Promoter binding of NF-kB p65 subunit in C. parvum-induced transactivation of miRNA genes in H69 cells.
C. parvum-
upregulated
mature miRNAs
Corresponding
pri-miRNAs
Uregulation of
pri-miRNA by
C. parvum
Inhibition of
upregulation
by SC-514
Potential NF-kB binding site(s)
within the promoter region
Promoter p65
binding by ChIP
Conformed
by promoter
reporter assay
miR-125b pri-miR-125b-1 ++ GGGGCTTTCC(21059 to 21050)* ++
GGGAATTTCA (22455 to 22446)* 22
pri-miR-125b-2 22 GAGAATTTCC (2893 to 2884) NS NS
miR-21 pri-miR-21 ++ GGGAATTTTC (+1167 to +1176) 22
GGGAATTCTC (+1395 to +1404) ++
miR-23b pri-miR-23b-27b-24-1 ++ GGGACTCTCC (21263 to 21254) ++
miR-27b
miR-24-1
miR-30b pri-miR-30b ++ AGGAATTTAC (2347 to 2338)* ++
miR-30c pri-miR-30c-1 + 2 TGGAATTACC (2689 to 2680) NS NS
pri-miR-30c-2 22 TGGGCTTTCC (2208 to 2199) NS NS
miR-16 pri-miR-15a-16-1 + 2 None NS NS
miR-15a
miR-16 pri-miR-15b-16-2 + 2 GGGATTTACC (2504 to 2495) NS NS
miR-15b
Expression of pri-miRNAs corresponding to C. parvum-upregulated mature miRNAs was quantified by real-time PCR. These showed significant upregulation in cells
following C. parvum infection were presented as ‘‘+’’ and those without significant increase were presented as ‘‘2’’. Effects of NF-kB inhibitor SC-514 on C. parvum-
induced upregulation of pri-miRNAs were also assessed by real-time PCR and presented as ‘‘+’’ (if the inhibitory effect was significant) and ‘‘2’’ (if not significant).
Putative promoter element for each miRNA gene was either based on previous studies as referred in Table 1 or identified by RACE-PCR in this study (indicated by
asterisks). Potential NF-kB binding site(s) in the promoter region was identified by the TFSEARCH (http://www.cbrc.jp/research/db/TFSEARCH.html) and MOTIF (http://
motif.genome.jp/). Positive promoter binding of p65 subunit to the predicted NF-kB binding site was confirmed by ChIP analysis and marked as ‘‘+’’; otherwise marked
as ‘‘2’’ if no p65 binding was detected. C. parvum-induced transactivation of miRNA gene by p65 was further confirmed by using luciferase reporter gene constructs
that spanned the promoter region of each individual gene. If C. parvum infection increased luciferase activity in cells transfected with the luciferase constructs
containing the binding site for p65 and this induction was blocked by SC-514, it was presented as ‘‘+’’; otherwise presented as ‘‘2’’. NS=not selected for further ChIP
analysis or luciferase reporter assay in this study. In such cases, these genes are most likely not regulated by p65 promoter binding because their transactivation was not
induced by C. parvum infection or the induced transactivation was not inhibited by SC-514 as assessed by real-time PCR. Refer to Figures S4, S5, S6 and S7 for details.
doi:10.1371/journal.ppat.1000681.t002
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miRNAs [21]. Cells were transfected with specific anti-miRs
(30 nM, Ambion) or a mixture of anti-miRs to miR-125b, miR-
23b and miR-30b (a total of 30 nM with 10 nM for each), and
then exposed to C. parvum. Following incubation with a constant
number of C. parvum sporozoites for 2 h to allow sufficient host-cell
attachment and cellular invasion [3,24], cells were washed with
culture medium to remove non-attached and non-internalized
parasites. Cells were then cultured for an additional 2 h or 22 h.
Parasite burden was assessed in the samples using a real-time PCR
approach as we previously reported [24]. The parasite burden
following exposure to C. parvum for 2 h was similar in all cultures,
including those transfected with the siRNA to Drosha or the
specific anti-miRs (Figure 5A and 5C), suggesting that those
miRNAs do not affect initial parasite host cell attachment and
cellular invasion. Additionally, SC-514 treatment did not impact
parasite burden at this time point (Figure 5A). Consistent with our
previous studies [24], a significant increase in parasite burden was
identified in SC-514-treated H69 cells 24 h after initial infection
(Figure 5B). Cells transfected with the siRNA to Drosha displayed
an increased parasite burden as compared to control cells
(Figure 5B). Interestingly, we also detected a significantly higher
parasite burden 24 h after initial infection in cells treated with the
anti-miRs to miR-125b, miR-23b, and miR-30b, as well as a
mixture of three anti-miRs, compared with that in control cells
(Figure 5D); anti-miRs to miR-16 and miR-21 did not impact
infection burden (Figure 5D). Increase of parasite burden 24 h
after initial infection in H69 cells treated with SC-514 or select
anti-miRs was further confirmed by immunofluorescent micros-
copy (Figure 5E).
The targets of a majority of known miRNAs are still yet to be
identified. C. parvum-responsive miRNAs may regulate the
expression of proteins of various functions related to epithelial
anti-C. parvum defense. Using computational analyses as previously
reported [19,37–39], we identified a variety of potential targets of
C. parvum-responsive miRNAs selected on the basis of their known
involvement in immune related responses (Table S3).
Discussion
There is emerging evidence that miRNAs play a critical role in
the regulation of both innate and adaptive immunity [17–19]. A
better understanding miRNA expression changes in epithelial cells
following C. parvum infection will provide new insights in miRNA-
associated epithelial defense to C. parvum. Using an in vitro model of
human biliary cryptosporidiosis, we report significant alterations in
miRNA expression profiles in epithelial cells following C. parvum
infection. Our analysis of miRNAs upregulated by C. parvum in H69
cells revealed that mir-125b-1, mir-23b-27b-24-1, mir-21, and mir-
30b genes are transactivated via potential promoter binding of the
NF-kB p65 subunit. These data provide several insights relevant to
miRNA expression regulation in cholangiocytes following C. parvum
infection. First, similar to the regulation of miRNA genes in other
cells [16,40,41], promoter binding of transcription factors regulates
miRNA genes in epithelial cells in response to C. parvum infection.
Therefore, transcription factor-mediated miRNA expression and
subsequent gene regulation at the posttranscriptional level through
miRNA targeting may be an important element of host responses
against C. parvum infection. Since similar alterations in miRNA
expression profile were identified in LPS-treated cells, this
observation may also be relevant to cellular gene regulation in
general. Second, transactivation of miRNA genes that produce the
same mature miRNA can be differentially controlled. Specifically,
both mir-125b-1 and mir-125b-2 genes can produce mature miR-
125b, but only transactivation of mir-125b-1 gene was detected in
cells following C. parvum infection. Indeed, differential activation of
genes for the same mature miRNA molecule has been previously
reported [31]. Finally, transactivation of genes of cluster miRNAs
or as introns in other gene alleles may be controlled by the same
promoter element. Of note, miR-23b, miR-27b and miR-24 are
cluster gene miRNAs and co-transcribed with a host gene, C9orf3
[31]. C. parvum infection upregulates expression of the mature forms
of these three miRNAs, as well as pri-miR-23b-27b-24-1 and the
host gene transcript, C9orf3. Our data are consistent with recent
studies demonstrating transcriptional control of genes that code
cluster miRNAs or that encode both miRNAs and other host
transcripts [31,32].
The NF-kB family of transcription factors consists of five
members, p50, p52, p65 (RelA), c-Rel, and RelB [8]. The
transcription activation domain (TAD) necessary for the positive
regulation of gene expression is present only in p65, c-Rel, and
RelB [8]. Thus, promoter binding of p65, c-Rel and RelB is
usually associated with gene transactivation [8,42–44]. Because
they lack TADs, p50 and p52 may repress transcription unless
they associate with a TAD-containing NF-kB family member or
another protein capable of coactivator recruitment [8,45,46].
Increased nuclear translocation of p65 and p50 was previously
reported in human cholangiocytes following C. parvum infection
[28]. In this study, we demonstrated that promoter binding of the
NF-kB p65 subunit is required for transactivation of the mir-125b-
1, mir-23b-27b-24-1, mir-21 and mir-30b genes in cells following C.
parvum infection. Although transactivation of mir-30c-1 and mir-
15b-16-2 genes was observed in C. parvum-infected cells and
potential NF-kB binding sites were identified in their promoter
elements, inhibition of p65 activation failed to inhibit transactiva-
tion of either mir-30c-1 or mir-15b-16-2 in H69 cells following C.
parvum-infection. In addition, miR-146b, miR-155, and miR-9
have been reported to be NF-kB-dependent miRNAs in
monocytes or neutrophils [15,47,48]. Although miR-146b and
miR-155 are expressed in cholangiocytes, no upregulation of
either miR-146b or miR-155 was detected in H69 cells following
C. parvum infection. Given the complexity and variability in the
gene structure for each miRNA, it is obvious that multiple
mechanisms are involved in the transcriptional regulation of
human miRNA genes [32,33,49]. Therefore, transcription of
miRNA genes is expected to be a dynamic process in response to
the constant alterations in intracellular signals. miRNA expression
thus reflects the final integrated result of multiple interrelated
signals on miRNA transcription. In this regard, other transcription
factors, such as AP-1, c-myc, C/EBPa, may also be involved in the
transcriptional regulation of miRNA genes in epithelial cells in
response to C. parvum infection. Future studies will focus on
whether nuclear translocation of p50 is involved in the C. parvum-
induced down-regulation of miRNA expression.
miRNAs have been identified in both mammalian and
nonmammalian cells including virus and parasites [9,14,50,51].
Expression of miRNAs in C. parvum has not yet been examined and
whether C. parvum-derived miRNAs can be localized in infected
host cells is unknown. Nevertheless, the probes used in the
microarray analysis in this study are human-miRNA specific with
minimal cross-interaction with known miRNAs from other species.
Cells of sham-infection control (host cells plus heat-inactivated C.
parvum oocysts) displayed a similar expression profile of human
miRNAs compared with non-infected control cells as assessed by
microarray analysis. Finally, by Northern blot and real-time PCR,
no positive signal was detected in C. parvum RNA alone using the
probes/primers for selected human miRNAs, confirming host-cell
specificity of detected miRNAs.
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PLoS Pathogens | www.plospathogens.org 8 December 2009 | Volume 5 | Issue 12 | e1000681Figure 5. Functional inhibition of selected p65-dependent miRNAs in cholangiocytes increases C. parvum infection burden in vitro.
(A) A similar number of parasites was detected in cells transfected with Drosha siRNA or treated with SC-514 after initial exposure to C. parvum for 2 h
as quantified by real-time PCR. (B) Transfection of cells with Drosha siRNA or treated with SC-514 increased C. parvum infection burden in
cholangiocytes in vitro 24 h after initial exposure to the parasite. (C) Effects of anti-miRs on C. parvum after initial exposure to C. parvum for 2 h. (D)
Transfection of cells with anti-miRs on C. parvum infection burden in cholangiocytes 24 h after initial exposure to the parasite. *, p,0.05 vs. non-
treated cells or cells transfected with a control siRNA (in B) or non-specific control anti-miR (in D). (E) Effects of anti-miRs or SC-514 on C. parvum
burden in cholangiocytes in vitro 24 h after initial exposure to the parasite as assessed by immunofluorescent microscopy. C. parvum parasites were
stained in green and nuclei in blue. Bars=5 mm.
doi:10.1371/journal.ppat.1000681.g005
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immune defenses to microbial infection including parasites
[4,52]. We previously demonstrated that TLR4 and TLR2 are
involved in cholangiocyte immune response to C. parvum infection
via activation of NF-kB [5]. Here, we expanded our previous
studies by demonstrating that miRNAs may also regulate TLR/
NF-kB-mediated epithelial anti-C. parvum defense. We indentified
a panel of miRNA genes that are transactivated via p65 promoter
binding in cholangiocytes in response to C. parvum infection.
Transfection of cells with anti-miRs to miR-125b, miR-23b or
miR-30b, but not anti-miRs to miR-16 or miR-21, significantly
increased parasite burden in cholangiocytes. The molecular
mechanisms by which C. parvum-responsive miRNAs modulate
epithelial anti-C. parvum defense are largely unclear. Previous
studies demonstrated that let-7 regulates TLR4 expression and is
involved in epithelial defense against C. parvum [24]. Various
immune related genes are identified as potential targets for these
C. parvum-responsive miRNAs using computational analyses. The
concept that a pathogen encodes mRNAs targeted by host
miRNAs has recently emerged as an important mechanism of
host anti-viral defense [21]. Likewise, it is of interest to test the
possibility that host cell miRNAs target the internalized parasite
mRNAs and silence genes of the pathogen. The direct C. parvum-
host cell cytoplasmic tunnel-connection [53] could mediate
exchange of molecules, including miRNAs, between the host cells
and internalized parasite. Further investigation should test
whether p65 promoter binding transactivates LPS-responsive
miRNA genes. This also raises the possibility that transactivation
of miRNA genes through promoter binding of NF-kB subunits
may be involved in host anti-microbial responses in general.
In summary, this first miRNA profiling in cholangiocytes in
response to C. parvum infection in vitro revealed significant
alterations in cellular miRNA expression. The mechanism by
which C. parvum induces upregulation of a panel of miRNAs in
cholangiocytes involves transactivation of miRNA genes through
promoter binding of the NF-kB p65 subunit. In addition,
functional inhibition of the upregulated miRNAs increases C.
parvum infection burden in cholangiocytes in vitro thereby
implicating these miRNAs in host cell defense to the parasite.
These data demonstrate a key role for miRNAs in epithelial
immune responses against C. parvum infection and may provide
new insights into general mechanisms of the regulation of
epithelial anti-microbial immunity.
Materials and Methods
C. parvum and human cholangiocyte cell line
C. parvum oocysts of the Iowa strain were purchased from a
commercial source (Bunch Grass Farm, Deary, ID). H69 cells (a
gift of Dr. D. Jefferson, Tufts University) are SV40 transformed
normal human cholangiocytes originally derived from liver
harvested for transplant. These cholangiocytes continue to express
biliary epithelial cell markers, including cytokeratin 19, gamma
glutamyl transpeptidase and ion transporters consistent with
biliary function and have been extensively characterized [26].
In vitro infection model and infection assay
An in vitro model of human biliary cryptosporidiosis using H69
cells was employed in these studies. Before infecting cells, C. parvum
oocysts were treated with 1% sodium hypochlorite on ice for
20 min followed by extensive washing with DMEM-F12 medium.
Oocysts were then added to the cell culture to release sporozoites
to infect cells [54]. Infection was performed in culture medium
(DMEM-F12 with 100 U/ml penicillin and 100 mg/ml strepto-
mycin) containing viable C. parvum oocysts (oocysts with host cells
in a 5:1 ratio). Inactivated organisms (treated at 65uC for 30 min)
were used for sham infection controls. All experiments were
performed in triplicate. For the inhibition experiments, SC-514
(Calbiochem) was added to the medium. Cells were pre-treated
with SC-514 for 1 h prior to C. parvum infection. SC-514 was used
at a concentration of 100 mM, which showed no cytotoxic effects
on H69 cells or on C. parvum sporozoites, in these studies.
Real-time PCR and immunofluorescent microscopy were used
to assay C. parvum infection as previously reported [24]. Briefly,
primers specific for C. parvum 18s ribosomal RNA (forward: 59-
TAGAGATTGGAGGTTGTTCCT-39 and reverse: 59-CTCCA-
CCAACTAAGAACGGCC-39) were used to amplify the cDNA
specific to the parasite. Primers specific for human plus C. parvum
18s were used to determine total 18s cDNA [24]. Data were
expressed as copies of C. parvum 18s vs total 18s. For immuno-
fluorescent microscopy, cells were fixed with 2% paraformalde-
hyde and incubated with a polyclonal antibody against C. parvum (a
gift from Dr. Guan Zhu, Texas A&M University) followed by anti-
rabbit FITC-conjugated secondary antibody (Molecular Probes)
and co-staining with 49, 6-diamidino-2-phenylindole (DAPI,
5 mM) to stain cell nuclei. Labeled cells were assessed by confocal
laser scanning microscopy.
miRCURY
TM LNA array analysis of miRNAs
The Exiqon (Vedbaek, Denmark) miRCURY LNA microRNA
arrays and service to process the samples were used [27]. Briefly,
H69 cells were grown to 80% confluence and exposed to C. parvum
oocysts for 12 h or LPS (1 mg/ml) for 8 h. Total RNAs from H69
cells or C. parvum oocysts were prepared with the mirVana
TM
miRNA Isolation Kit according to the manufacturer’s instruction
(Ambion). The quality of isolated RNAs was verified by an Agilent
2100 Bioanalyzer profile (Figure S1). A mixture of equal amounts of
total RNAs from the control and C. parvum-infected cells were used
as the reference pool. A total of 2 mg RNA from each sample was
then labeled with the Hy5
TM fluorescent label and the reference
pool labeled with Hy3
TM using the miRCURY
TM LNA Array
labeling kit (Exiqon). The labeled samples and reference pool were
then mixed pair-wise and hybridized to the miRCURY
TM LNA
array containing capture probes targeting all human miRNAs listed
inthemiRBASEversion 8.1(Exiqon). Afterhybridization, theslides
were scanned and quantified signals normalized by Exiqon using
the global Lowess (Locally Weighted Scatterplot Smoothing)
regression algorithm. Normalized Hy5/Hy3 ratios were used for
further analysis as previously reported [55–57].
Bead-based multiplex sandwich immunoassays
A bead-based multiplex sandwich immunoassay, read with a
Luminex 200 system (Luminex), was used to measure the
concentrations of selected miRNAs as previously reported [57].
Briefly, total cellular RNAs are isolated using the mirVana
TM
miRNA Isolation Kit (Ambion). An amount of 0.5 mg of total
RNAs was used for Biotin-labeling using the FlexmiR MicroRNA
Labeling Kit for selected miRNAs (Luminex). Signals for miRNAs
were recorded and standardized to the standard beads according
to the manufacturer’s instructions (Luminex).
Real-time PCR
For real-time PCR analysis of mature miRNAs, total RNAs were
extracted using the mirVana
TM miRNA Isolation kit (Ambion). An
amount of 0.05 mg total RNAs was reverse-transcribed by using the
Taqman MicroRNA Reverse Transcription Kit (Applied Biosys-
tems). Comparative real-time PCR was performed in triplicate
using Taqman Universal PCR Master Mix (Applied Biosystems) on
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miRNA-specific primers and probes were obtained from Applied
Biosystems. Normalization was performed by using RNU6B
primers and probes. Relative expression was calculated by using
the comparative CT method [56].
For analysis of pri-miRNAs, total RNA was isolated from cells
with Trizol reagent (Ambion). RNAs were treated with DNA-
free
TM Kit (Ambion) to remove any remaining DNA. Compar-
ative real-time PCR was performed by using the SYBR Green
PCR Master Mix (Applied Biosystems). Specific primers for pri-
miRNAs were listed in Table S2. All reactions were run in
triplicate. The Ct values were analyzed using the comparative Ct
(DDCt) method and the amount of target was obtained by
normalizing to the endogenous reference (GAPDH) and relative to
the control (non-treated cells) [58].
Northern blot
Total RNAs harvested as above were run on a 15% Tris/
Borate/EDTA (90 mM Tris/64.6 mM boric acid/2.5 mM
EDTA, pH 8.3)–urea gel (Invitrogen) and transferred to a Nytran
nylon transfer membrane (Ambion). LNA DIG-probes for selected
miRNAs (Exiqon) were hybridized using UltraHyb reagents
(Ambion) according to the manufacturer’s instructions with blotted
snRNA RNU6B as a control.
59-RACE PCR
59-RACE PCR was utilized to identify 59 end of miRNA primary
transcripts to localize the start sites of mir-125b-1, mir-30b and mir-
30d. Primer sequences are listed in Table S2. The SMART
TM
RACEcDNAAmplification Kit(Clontech) wasused fortheanalysis.
Total RNA was isolated for H69 cells treated with a Drosha siRNA
(Santa Cruz biotechnology) as previously reported [32].
ChIP
ChIP analysis was performed with a commercially available
ChIP Assay Kit (Upstate Biotechnologies) in accordance with the
manufacturer’s instructions. In brief, 1610
6 H69 cells were
cultured in 15-cm culture dishes and exposed to C. parvum in the
presence or absence of SC-514 for 8 h. The chromatin fraction
was immunoprecipitated for overnight at 4uC using anti-NF-kB
p65 (Upstate Biotechnologies). PCR amplification was performed
in a total volume of 25 ml with specific primers. The forward and
reverse primers used for each gene were listed in Table S2.
Luciferase reporter constructs and luciferase assay
Promoters of miRNAs were amplified by PCR from human
genomic DNA. PCR primers were listed in Table S2. The PCR
products were separated by agarose gel electrophoresis, and the
DNA fragments then isolated and cloned in the restriction enzyme
digested pGL3 Basic Vector (Promega) using T4 DNA ligase
(Fisher scientific). All constructs were confirmed by sequencing.
Mutations were introduced into the NF-kB binding sites using the
QuikChange site-directed mutagenesis kit (Stratagene). H69 cells
were transfected with each reporter construct for 24 h and then
exposed to C. parvum oocysts for 8 h in the presence or absence of
SC-514 followed by assessment of luciferase activity. Luciferase
activities were then measured and normalized to the control b-gal
level. The luciferase activity of each construct was compared with
that of the promoterless pGL3 basic vector.
Supporting Information
Table S1 miRNA expression profile in cholangiocytes following
C. parvum infection and LPS stimulation. Data represent the
mean6SE of the log2 (Hy5/Hy3) ratios from non-infected cell
cultures (n=3), C. parvum infected cultures (n=3), LPS treated
cultures (n=3), and one cell culture exposed to heated-inactivated
C. parvum (Sham) by using the miRCURY
TM LNA Array (Version
8.1).
a,p ,=0.05;
b, 0.05,p,=0.20, compared with non-
infected cells; NA=not detectable.
Found at: doi:10.1371/journal.ppat.1000681.s001 (0.09 MB PDF)
Table S2 Primers used for PCR and construct generating. Listed
in this table are all the primers used in this study for the real-time
PCR and RACE PCR, as well as those for ChIP analysis and
construct generating.
aRestriction enzyme sites were indicated by
lowercase letters.
Found at: doi:10.1371/journal.ppat.1000681.s002 (0.02 MB PDF)
Table S3 Prediction of immune-related target genes of C.
parvum-responsive miRNAs. Prediction of immune-related target
genes for C. parvum-responsive miRNAs was performed with the
computerlized predictive algorithms as previously reported
[19,37–39]. Some of the predicted targets have been experimen-
tally confirmed [24,25,27,59,60] and the corresponding miRNAs
are in red font.
Found at: doi:10.1371/journal.ppat.1000681.s003 (0.02 MB PDF)
Figure S1 Quality control of RNA. Total RNAs from cells were
prepared with the mirVana
TM miRNA Isolation Kit according to
the manufacturer’s instructions (Ambion). The quality of the
isolated RNAs was verified by examining the Agilent 2100
Bioanalyzer profile of the sample. Representative RNA profiles
from non-infected H69 cells (A), cells exposed to live (B) and heat-
inactivated C. parvum oocysts (C) are shown.
Found at: doi:10.1371/journal.ppat.1000681.s004 (1.62 MB TIF)
Figure S2 Promoter binding of p65 transactivates the IL-8 gene
in cholangiocytes in response to C. parvum infection. (A) p65-
dependent upregulation of IL-8 mRNA in cholangiocytes
following C. parvum infection. Bars represent the levels of IL-8
mRNA in cells following C. parvum infection in the presence or
absence of SC-514 as assessed by real-time PCR. (B) A schematic
diagram shows the structure of IL-8 gene. ChIP analysis
demonstrated increased binding of p65 to the binding site at IL-8
promoter in cells following infection. *, p,0.05 vs. non-infected
cells; #,p ,0.05 vs. C. parvum infected cells.
Found at: doi:10.1371/journal.ppat.1000681.s005 (0.28 MB TIF)
Figure S3 Nuclear translocation of p65 in cholangiocytes cells
induced by C. parvum. Cells were exposed to C. parvum for various
periods of time and nuclear extracts obtained as described in
Protocol S1. The NF-kB p65 subunit was detected by Western
blot. Actin was used as a loading control. Representative Western
blots are shown.
Found at: doi:10.1371/journal.ppat.1000681.s006 (0.61 MB TIF)
Figure S4 Promoter binding of p65 transactivates mir-21 gene to
increase miR-21 expression in biliary epithelial cells in response to
C. parvum infection. (A) p65-dependent upregulation of pri-miR-21
in cholangiocytes following C. parvum infection. A schematic
diagram illustrates the structure of the mir-21 gene that encodes
human miR-21. Bars represent the expression levels of pri-miR-21
in cells following C. parvum infection in the presence or absence of
SC-514 as assessed by real-time PCR. (B) C. parvum increases
promoter binding of p65 to the mir-21 gene. ChIP analysis revealed
increased binding of p65 to the promoter binding site at +1395,
but not at +1167 in H69 cells following infection. (C) H69 cells
were transfected with various luciferase reporter constructs
covering the potential binding sites of the mir-21 promoter and
then exposed to C. parvum in the presence or absence of SC-514. A
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activity in transfected cells. (D) H69 cells were co-transfected with
the pCMV-p65 to overexpress p65 and the luciferase reporter
construct containing the mir-21 promoter. Different from the
results in C. parvum-infected cells, a significant increase of luciferase
reporter activity was detected in cells co-transfected with the
pCMV-p65 and the mutant at +1167. *, p,0.05 vs. the non-
infected control (in A and C) or empty pCMV vector control (in
D); #,p ,0.05 vs. C. parvum infected cells (in A and C).
Found at: doi:10.1371/journal.ppat.1000681.s007 (0.63 MB TIF)
Figure S5 Promoter binding of p65 transactivates the mir-23b-
27b-24-1 cluster gene in cholangiocytes in response to C. parvum
infection. (A) p65-dependent upregulation of pri-miR-23b-27b-24-
1 in cholangiocytes following C. parvum infection. A schematic
diagram shows the structure of the mir-23b-27b-24-1 cluster gene.
Real-time PCR was used to assess the expression levels of pri-
miRNA-23b-27b-24-1 and C9orf3 following C. parvum infection in
the presence or absence of SC-514. (B) C. parvum increases
promoter binding of p65 to the mir-23b-27b-24-1 cluster gene. The
schematic diagram shows one potential NF-kB binding site in the
promoter element of mir-23b-27b-24-1. ChIP analysis revealed
increased binding of p65 to the binding site at 21254 of the
promoter in cells following infection. (C) H69 cells were
transfected with luciferase gene reporter constructs with or without
mutations in the p65 binding site of the promoter and then
exposed to C. parvum in the presence or absence of SC-514. (D)
H69 cells were co-transfected with the pCMV-p65 to overexpress
p65 and the luciferase reporter gene construct containing the
promoter. Cells were then cultured for 24 h followed by
measurement of luciferase activity. *, p,0.05 vs. the non-infected
control (in A and C) or empty pCMV vector control (in D); #,
p,0.05 vs. C. parvum infected cells (in A and C).
Found at: doi:10.1371/journal.ppat.1000681.s008 (0.76 MB TIF)
Figure S6 Promoter binding of p65 transactivates the mir-30b
gene to increase miR-30b expression in biliary epithelial cells
following C. parvum infection. (A) p65-dependent upregulation of
pri-miR-30b, but not pri-miR-30d, in cholangiocytes following C.
parvum infection. The expression levels of pri-miRNAs in cells
following C. parvum infection were assessed by real time PCR in the
presence or absence of SC-514. Treatment of cells with SC-514
blocked C. parvum-induced increase of pri-miR-30b, suggesting
p65-dependent miR-30b expression. (B) We performed 59-RACE
PCR to identify the 59end of pri-miR-30d and identified a
potential p65 binding site at 2472 of its upstream sequence. H69
cells were transfected with the luciferase gene reporter construct
covering the potential p65 binding site within the putative
promoter of mir-30d and then exposed to C. parvum. These results
support that pri-miR-30b and pri-miR-30d are not transcribed
from the same gene in human cholangiocytes, inconsistent with
previous results suggesting that pri-miR-30b and pri-miR-30d may
be transcribed from the same gene on chr8 [31,40]. (C) To clarify
how p65 is involved in the transactivation of miR-30b gene
transactivation, we performed 59-RACE PCR but failed to amplify
the corresponding sequence (data not shown). Nevertheless,
database analysis revealed one potential binding site for NF-kB
in the upstream sequence of miR-30b precursor. ChIP analysis
detected an increased binding of p65 to this region in cells
following C. parvum infection. (D) Luciferase reporter gene analysis
demonstrated a significant increase in luciferase reporter activity in
cells following C. parvum infection or overexpressed with p65.
*, p,0.05 vs. the non-infected control (in A and D) or empty
pCMV vector control (in E); #,p ,0.05 vs. C. parvum infected cells
(in A and D).
Found at: doi:10.1371/journal.ppat.1000681.s009 (0.73 MB TIF)
Figure S7 p65-independent expression of miR-30c and miR-16
in cholangiocytes in response to C. parvum infection. (A and B)
miR-30c is transcribed from two genes, mir-30c-1 and mir-30c-2,
localized on chr1 and chr6, respectively [31]. Real-time PCR
analysis revealed an increase of pri-miR-30c-1(A), but not pri-
miR-30c-2 (B), in H69 cells following C. parvum infection.
Treatment of cells with SC-514 failed to block C. parvum-induced
expression of pri-miR-30c-1 (A). (C and D) miR-16 is transcribed
from two genes, mir-15a-16-1 and mir-15b-16-2 localized on chr13
and chr3 and clustered with miR-15a and miR-15b, respectively
[31]. Increased expression of pri-miR-15a-16-1 (at 12 h; C) and
pri-miR-15b-16-2 (at 8 h and 12 h; D) was detected in H69 cells
after C. parvum infection. Treatment of cells with SC-514 failed to
block either pri-miR-15a-16-1 (C) or pri-miR-15b-16-2 (D).
*, p,0.05 vs. the non-infected control.
Found at: doi:10.1371/journal.ppat.1000681.s010 (0.58 MB TIF)
Protocol S1 Nuclear translocation of p65.
Found at: doi:10.1371/journal.ppat.1000681.s011 (0.01 MB PDF)
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